$125 | Single User
$250 | Site License
$375 | Global License

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-02-2018]

Published by Global Data: 28 Feb 2018 | 195270 | In Stock

Introduction

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities across the world. The company markets its products in North America, Latin America, the Caribbean, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Feb 06,2018: ANGLE: Research Grant From Abbott

Jan 24,2018: Abbott Reports Fourth-Quarter 2017 Results

Oct 30,2017: Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease With Xience Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery

Oct 18,2017: Abbott Reports Third-Quarter 2017 Results

Sep 22,2017: Abbott and the Abbott Fund Provide Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-02-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    Section 1 - About the Company 6

    Abbott Laboratories - Key Facts 6

    Abbott Laboratories - Key Employees 7

    Abbott Laboratories - Key Employee Biographies 9

    Abbott Laboratories - Major Products and Services 10

    Abbott Laboratories - History 13

    Abbott Laboratories - Company Statement 26

    Abbott Laboratories - Locations And Subsidiaries 27

    Head Office 27

    Other Locations & Subsidiaries 27

    Section 2 – Company Analysis 45

    Company Overview 45

    Abbott Laboratories - Business Description 45

    Business Segment: Cardiovascular and Neuromodulation Products 45

    Overview 45

    Performance 45

    Business Segment: Diagnostics 46

    Overview 46

    Performance 46

    Business Segment: Established Pharmaceutical Products 46

    Overview 46

    Performance 47

    Business Segment: Nutritionals 47

    Overview 47

    Performance 47

    Business Segment: Other Products 47

    Overview 47

    Performance 48

    Geographical Segment: All Other Countries 48

    Performance 48

    Geographical Segment: Brazil 48

    Performance 48

    Geographical Segment: Canada 48

    Performance 48

    Geographical Segment: China 48

    Performance 48

    Geographical Segment: Colombia 48

    Performance 48

    Geographical Segment: Germany 48

    Performance 48

    Geographical Segment: India 49

    Performance 49

    Geographical Segment: Italy 49

    Performance 49

    Geographical Segment: Japan 49

    Performance 49

    Geographical Segment: Netherlands 49

    Performance 49

    Geographical Segment: Russia 49

    Performance 49

    Geographical Segment: Switzerland 49

    Performance 49

    Geographical Segment: United Kingdom 49

    Performance 49

    Geographical Segment: US 50

    Performance 50

    Geographical Segment: Vietnam 50

    Performance 50

    R&D Overview 50

    Abbott Laboratories - SWOT Analysis 51

    SWOT Analysis - Overview 51

    Abbott Laboratories - Strengths 51

    Abbott Laboratories - Weaknesses 52

    Abbott Laboratories - Opportunities 53

    Abbott Laboratories - Threats 54

    Abbott Laboratories - Key Competitors 55

    Section 3 – Company Financial Ratios 56

    Financial Ratios - Capital Market Ratios 56

    Financial Ratios - Annual Ratios 57

    Performance Chart 60

    Financial Performance 60

    Financial Ratios - Interim Ratios 61

    Financial Ratios - Ratio Charts 62

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 63

    Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 63

    Abbott Laboratories, Medical Equipment, Deals By Type, 2012 to YTD 2018 64

    Abbott Laboratories, Recent Deals Summary 65

    Section 5 – Company’s Recent Developments 66

    Feb 25, 2018: Abbott: 'Top Innovator' With 20 Breakthroughs 66

    Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 67

    Nov 29, 2017: Solvay unveils Zeniva ZA-600 CF30 PEEK, a high-strength, injection moldable polymer for implantable devices 70

    Oct 30, 2017: Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease With Xience Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery 71

    Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results 72

    Sep 29, 2017: Alere Announces the U.S. Department of Justice Closes Investigation 75

    Sep 28, 2017: Alere Announces Settlement with SEC 76

    Sep 28, 2017: Alere Announces Agreement in Principle to Settle with the U.S. Department of Justice 77

    Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With Million to Help Families Affected by Hurricane Irma 78

    Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 79

    Section 6 – Appendix 80

    Methodology 80

    Ratio Definitions 80

    About GlobalData 84

    Contact Us 84

    Disclaimer 84

List Of Tables
in Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-02-2018]

List of Tables

Abbott Laboratories, Key Facts 6

Abbott Laboratories, Key Employees 7

Abbott Laboratories, Key Employee Biographies 9

Abbott Laboratories, Major Products and Services 10

Abbott Laboratories, History 13

Abbott Laboratories, Other Locations 27

Abbott Laboratories, Subsidiaries 27

Abbott Laboratories, Key Competitors 55

Abbott Laboratories, Ratios based on current share price 56

Abbott Laboratories, Annual Ratios 57

Abbott Laboratories, Annual Ratios (Cont...1) 58

Abbott Laboratories, Annual Ratios (Cont...2) 59

Abbott Laboratories, Interim Ratios 61

Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 63

Abbott Laboratories, Medical Equipment, Deals By Type, 2012 to YTD 2018 64

Abbott Laboratories, Recent Deals Summary 65

Currency Codes 80

Capital Market Ratios 80

Equity Ratios 81

Profitability Ratios 81

Cost Ratios 82

Liquidity Ratios 82

Leverage Ratios 83

Efficiency Ratios 83

List Of Figures, Charts and Diagrams
in Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-02-2018]

List of Figures

Abbott Laboratories, Performance Chart (2013 - 2017) 60

Abbott Laboratories, Ratio Charts 62

Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 63

Abbott Laboratories, Medical Equipment, Deals by Type, 2012 to YTD 2018 64

Additional Details

Publisher

Global Data

Publisher Information

Reference

195270 | GDME1255FSA

Number of Pages

84

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Abbott Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update
SummaryAbbott Vascular Inc. (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Labor...
30 Mar 2016 by Global Data USD $750 More Info
Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
09 Mar 2016 by Global Data USD $250 More Info
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth st...
07 Mar 2016 by Global Data USD $125 More Info
Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
24 Feb 2016 by Global Data USD $250 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC), formerly TheraSense, Inc. a subsidiary of Abbott Laboratori...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical di...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into t...
11 Jan 2016 by Global Data USD $125 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC)formerly known as TheraSense, Inc., discovers, develops, manu...
15 Oct 2015 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott) is a medical diagnostic company. The company provides molecula...
15 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-02-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data